Detalhe da pesquisa
1.
Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery.
Int J Mol Sci
; 24(14)2023 Jul 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37511180
2.
Olaparib as first line in BRCA-mutated advanced ovarian carcinoma: Is it cost-effective in Spain?
Gynecol Oncol
; 164(2): 406-414, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34844775
3.
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer.
Future Oncol
; 17(29): 3781-3785, 2021 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34427115
4.
DNA damaging agents in ovarian cancer.
EJC Suppl
; 15: 67-72, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33240444
5.
Rare ovarian tumours. Other treatments for ovarian cancer.
EJC Suppl
; 15: 96-103, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-33240448
6.
Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer.
Int J Gynecol Cancer
; 29(6): 1050-1056, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31263024
7.
Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study.
Clin Transl Oncol
; 26(4): 1033-1037, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37682500
8.
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study).
Clin Cancer Res
; 30(1): 176-186, 2024 01 05.
Artigo
Inglês
| MEDLINE | ID: mdl-37527007
9.
Esophageal Infiltration by High-Grade Serous Ovarian Carcinoma: A Very Rare Case Report.
Case Rep Oncol
; 16(1): 1436-1442, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38028570
10.
The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer-A GEICO Study.
Cancers (Basel)
; 15(11)2023 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37296992
11.
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors-Results of Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey.
Cancers (Basel)
; 15(22)2023 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38001688
12.
SEOM-GEICO clinical guidelines on endometrial cancer (2021).
Clin Transl Oncol
; 24(4): 625-634, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35312947
13.
Multicenter Real-World Data of Subsequent Chemotherapy after Progression to PARP Inhibitors in a Maintenance Relapse Setting.
Cancers (Basel)
; 14(18)2022 Sep 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36139574
14.
Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial.
Ther Adv Med Oncol
; 14: 17588359221126149, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36172173
15.
Management of advanced ovarian cancer in Spain: an expert Delphi consensus.
J Ovarian Res
; 14(1): 72, 2021 May 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34039386
16.
Safety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial.
J Immunother Cancer
; 9(12)2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34893524
17.
Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial.
JAMA Oncol
; 6(11): 1766-1772, 2020 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33001143
18.
Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients.
Dis Markers
; 2017: 3098542, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28293063
19.
SEOM-GEICO clinical guidelines on endometrial cancer (2021)
Clin. transl. oncol. (Print)
; 24(4): 625-634, abril 2022. tab
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-203766